Sebaceous Gland Secretion in Parkinson's Disease During L-Dopa Treatment
Authors:
- Steven R. KohnSKSteven R. Kohn
- Peter E. PochiPPPeter E. Pochi
- John S. StraussJSJohn S. Strauss
- Daniel S. SaxDSDaniel S. Sax
- Robert G. FeldmanRFRobert G. Feldman
- William H. TimberlakeWTWilliam H. Timberlake
- 1 March 1973
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 60 (3) , 134-136
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- EFFECT OF LEVODOPA (L-DOPA) ON HUMAN HYPOPHYSEAL TROPHIC HORMONE RELEASE1The Journal of Clinical Endocrinology & Metabolism, 1971
- LEVODOPA IN ACNE VULGARISThe Lancet, 1971
- SEBUM-EXCRETION RATE AND SKIN-SURFACE LIPID COMPOSITION IN PARKINSON'S DISEASE BEFORE AND DURING THERAPY WITH LEVODOPAThe Lancet, 1971
- A New Approach to the Reduction of Sebum SecretionArchives of Dermatology, 1971
- L-Dopa for Seborrheic DermatitisNew England Journal of Medicine, 1970
- EFFECT OF L-DOPA ON SEBORRHŒA OF PARKINSONISMThe Lancet, 1970
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- Sebum Production and Fractional 17-ketosteroid Excretion in ParkinsonismJournal of Investigative Dermatology, 1962
- The Quantitative Gravimetric Determination of Sebum Production*Journal of Investigative Dermatology, 1961
- An Investigation of the Biology of the Human Sebaceous Gland11From the Department of Dermatology (Dr. Donald M. Pillsbury, Director), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.Journal of Investigative Dermatology, 1958